rivaroxaban우선순위 낮음근거 검토기타
LITERATURE DETAIL · PMID 42276017
Sonocrystallization approach in crystal habit modification for improving the pharmaceutical properties of Rivaroxaban.
Sonocrystallization approach in crystal habit modification for improving the pharmaceutical properties of Rivaroxaban.
- 저자
- Maan Singh, Madhukiran R Dhondale, Ashish K Agrawal, Dinesh Kumar
- 저널
- Ultrasonics sonochemistry
- 공개일
- 2026 Aug
- 연구 유형
- 기타
- DOI
- 10.1016/j.ultsonch.2026.107921
문헌 요약
Poor pharmaceutical material properties of active pharmaceutical ingredients (APIs) can result in suboptimal manufacturing and therapeutic outcomes. Rivaroxaban (RIV) was explored as a model API due to its poor pharmaceutical properties and challenging industrial processability. In this research, crystal habit modification (CHM) of RIV was explored via so…
PV 검토 포인트
누적 안전성 근거로 분류하고 기존 시그널과의 일관성을 확인합니다.